Güllü Koca, T. Et Al. 2022. Comparison of Clinical Data and Treatment Responses of Patients with Essential Thrombocythemia Using Anagrelide by JAK2 Gene Mutation Status. UNIVERSOS JURÍDICOS , vol.4, no.1 , 7-11.

Güllü Koca, T., Özkalemkaş, F., Özkocaman, V., Ersal, T., & Esenbuğa, Ş., (2022). Comparison of Clinical Data and Treatment Responses of Patients with Essential Thrombocythemia Using Anagrelide by JAK2 Gene Mutation Status. UNIVERSOS JURÍDICOS , vol.4, no.1, 7-11.

Güllü Koca, Tuba Et Al. "Comparison of Clinical Data and Treatment Responses of Patients with Essential Thrombocythemia Using Anagrelide by JAK2 Gene Mutation Status," UNIVERSOS JURÍDICOS , vol.4, no.1, 7-11, 2022

Güllü Koca, Tuba G. Et Al. "Comparison of Clinical Data and Treatment Responses of Patients with Essential Thrombocythemia Using Anagrelide by JAK2 Gene Mutation Status." UNIVERSOS JURÍDICOS , vol.4, no.1, pp.7-11, 2022

Güllü Koca, T. Et Al. (2022) . "Comparison of Clinical Data and Treatment Responses of Patients with Essential Thrombocythemia Using Anagrelide by JAK2 Gene Mutation Status." UNIVERSOS JURÍDICOS , vol.4, no.1, pp.7-11.

@article{article, author={Tuba Güllü Koca Et Al. }, title={Comparison of Clinical Data and Treatment Responses of Patients with Essential Thrombocythemia Using Anagrelide by JAK2 Gene Mutation Status}, journal={UNIVERSOS JURÍDICOS}, year=2022, pages={7-11} }